BioGenerator Ventures
Venture capitalSt. Louis · Pre-Seed–Series B · 1 people tracked
Find your way into BioGenerator Ventures
373 people in our graph share verified history with the BioGenerator Ventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
BioGenerator Ventures provides catalytic investments to life sciences companies across human health and plant/agriculture sciences, including therapeutics, diagnostics, medical devices, research tools, and healthcare. It combines funding with the BioGenerator Labs engine of company-building resources — technology, talent, proof-of-concept grants, coaching, grant training, and laboratory space — to accelerate new ventures. The firm often supports companies from pre-company licensing and formation through early financing rounds, leading initial financings, orchestrating additional investors, and running diligence processes. It is closely tied to the St. Louis innovation ecosystem and frequently spins ventures out of local academic institutions.
Source: firm website, verified Aug 3, 2026.
Team · 1 people
from the firm's website
Founder mafia
3 people who came through BioGenerator Ventures went on to found or lead other companies.
What they invest in
from 22 of 26 portfolio companiesBiotech ×18Healthtech ×12Medical Devices ×12Deep Tech ×7AgTech ×6AI & Machine Learning ×6Digital Health ×4Cleantech ×2
HQs:United States×17
Who they back
founder profiles across 11 portfolio companiesFounding team size:solo founder×62 founders×33 founders×14+ founders×1
Where their founders studiedfrom 11 founders with education data
University of Minnesota ×3
Where their founders worked beforefrom 11 founders with career history
Washington University in St. Louis ×2Washington University School of Medicine ×2
Investments · 26 tracked
founders shown can be your intro pathBy year:2025 · 12024 · 22023 · 12022 · 12018 · 16 dated
Pairidex offers FusionMRD, a personalized digital droplet PCR (ddPCR) assay that detects and quantifies oncogenic gene fusions from a standard peripheral blood sample to monitor treatment response and minimal residual disease in gene fusion-driven blood cancers such as leukemia.
BiotechDigital HealthHealthtechMedical DevicesSt. Louis, US
Grant Challen(Co-Founder & Scientific Advisor)inAllyson Mayer(Interim COO)inAndrew Young(Founder & CSO)Paul Kortschak(CEO)in
BoardTodd Druley(Director)
Board seatCrystal Winkeler· per SEC Form D
Co-investorsiSelect Fund
Cadre Bioscience partners with innovators to develop and bring new therapeutics to clinical application through drug development.
BiotechDeep TechHealthtechMedical DevicesSt. Louis, US
Bob Karr(Executive Chairman & CEO)
Benson Hill develops soybean seed varieties using plant genetics and AI-driven plant science to produce more nutritious and energy-dense soy for agriculture and food markets.
AgTechAI & Machine LearningFoodTech
Co-investorsActivant CapitaliSelect FundLewis & Clark VenturesManta Ray VenturesMercury FundProlog Ventures+1 more
BIOIO develops a genetics-based platform for elucidating drug mechanisms of action, combining decades of research in pharmacology with big data and automation to accelerate drug discovery and development.
AI & Machine LearningBiotechDeep TechLongevity
Dr. Peterson
Co-investorsMissouri Technology CorporationquadraScope Venture Fund
Canopy Biosciences (Bruker Spatial Biology) develops spatial biology instruments and assays for analyzing gene expression, RNA, and proteins in tissue samples.
BiotechHealthtechMedical DevicesSaint Louis, US
EDWARD WEINSTEIN(President, Chief Executive Officer and Manager)inCRYSTAL WINKELER(Chief Operating Officer)CHARLES BOLTEN(Director)DAVID KINGSLEY(Director)
BoardDAVID SMOLLER(Director)in
Co-investorsAmpersand
Cortex is an innovation district in St.
Impact & Social GoodSt. Louis, US
CoverCress Inc. develops agricultural products and seeds that enable farmers to convert idle winter fields into profitable crops.
AgTechCleantechClimate TechEnergyOlivette, US
Jim Hedges(CEO)in
Co-investorsFulcrum Global CapitalPrelude VenturesProlog VenturesCultivation Capital
Edison Agro Sciences develops bio-based synthetic rubber from sunflower crops as an alternative to petrochemical and natural rubber for industrial applications.
AgTechBiotechCleantechNew MaterialsSt. Louis, US
David Woodburn(Executive Officer, Director)inMatthew B Crisp(Executive Officer, Director)Thomas Hohn(Executive Officer, Director)inTom Christensen(Executive Officer, Director, Promoter)
BoardDan Broderick(Director)Matt Helms(Director)
Geneoscopy develops innovative diagnostic technologies for gastrointestinal health, specifically focused on the detection of colorectal cancer.
BiotechDigital HealthHealthtechMedical DevicesSt. Louis, US
Andrew Barnell(Chief Executive Officer & Co-founder)inErica Barnell(Co-founder)in
Co-investorsDorm RoomiSelect FundMissouri Technology CorporationCultivation Capital
Immunophotonics is a clinical-stage biotech company developing novel treatments for solid-tumor cancers and infectious diseases by combining tumor ablation with systemic cancer immunotherapy.
BiotechDeep TechDigital HealthMedical DevicesSt. Louis, US
Dr. Hode(Co-Founder & Senior Fellow)Mr. Alleruzzo(Co-Founder & Director)Dr. Chen(Co-Founder)Dr. Robert Nordquist(Co-Founder)Luciano Alleruzzo(Director, Promoter)Wei Chen(Director, Promoter)
Co-investorsiSelect FundMissouri Technology CorporationCultivation Capital
KaloCyte develops ErythroMer, a dried, shelf-stable artificial red blood cell for use in emergency and trauma care when stored blood is unavailable or in short supply.
BiotechDeep TechHealthtechMedical DevicesBaltimore, US
Allan Doctor(Co-Founder & CSO)inDipanjan Pan(Co-Founder, Chief Technical Officer)inPhilip Spinella(Co-Founder, Chief Medical Officer)inDaniel Getman(Director)Gregory Lanza(Director)
Co-investorsBioAdvanceMaryland TEDCONYBC VenturesOld Line Capital PartnersTEDCO
Kypha develops clinical diagnostic tests for immune system biomarkers, particularly complement activity markers, and provides solutions for real-time immune insights across therapeutic areas.
BiotechDeep TechHealthtechMedical DevicesSt. Louis, US
Nick Staten(Executive Officer)inT. Scott Glover(Executive Officer)inPaul K. Olson(Executive Officer, Director)
BoardDavid Smoller(Director)inJames D. Marselis(Director)Peter Reinecke(Director)in
Co-investorsMissouri Technology CorporationSerra Ventures
MediBeacon develops biocompatible fluorescent tracer agents detected by skin sensors for clinical diagnostic applications including kidney function assessment and gastrointestinal permeability measurement.
AI & Machine LearningBiotechHealthtechMedical DevicesSaint Louis, US
Richard Dorshow(Executive Officer, Director)inTerence Stern(Executive Officer)inSteven Hanley(Executive Officer, Director)
BoardSteven Miller(Director)David Present(Director)Cherine Plumaker(Director)
Co-investorsMissouri Technology CorporationNewlin Investment Company LLC
Omniose develops a platform for bioconjugate vaccine development using glycoconjugation technology to create vaccines against bacterial pathogens like Group B Streptococcus and Klebsiella pneumoniae.
BiotechDeep TechHealthtechMedical DevicesSt. Louis, US
Dr. Harding(Primary Founder)Mario Feldman(Founder, Scientific Founder)Viliam PavliakBenjamin Moutierin
BoardDr. SzymanskiDr. Projan
Panome Bio provides metabolomics, proteomics, and multi-omics integration workflows along with a computational platform that analyzes and integrates diverse biological data types.
AI & Machine LearningBiotechDeep TechHealthtechSaint Louis, US
Edward Weinstein(Executive Officer, Director)inTom Cohen(Executive Officer)in
BoardDavid Smoller(Director)inDeval Lashkari(Director)inAlexander Herzick(Director)inRob Capone(Director)in
Co-investorsTelegraph Hill PartnersCultivation Capital
Plastomics develops trait delivery technology for agriculture using cell biology, plant tissue culture, transformation, and molecular biology methods.
AgTechBiotechSt. Louis, US
Jeffrey Staub(Executive Officer, Director)inElizabeth Gallegos(Executive Officer)in
BoardMartha Schlicher(Executive Officer, Director)inBrian Clevinger(Director)Charles Bolten(Director)Dave Duncan(Director)
Co-investorsFulcrum Global CapitaliSelect FundMissouri Technology CorporationCultivation CapitalProlog Ventures
RhoDx develops cell-free DNA and RNA enrichment technologies for liquid biopsy cancer diagnostics.
BiotechDigital HealthMedical Devices
Charlie Rodi(Founder and CSO)in
SentiAR builds CommandEP, an FDA-cleared mixed-reality holographic augmented reality platform for cardiac electrophysiology that converts real-time catheter data into hands-free 3D holograms and virtual screens for electrophysiologists during procedures.
AI & Machine LearningHealthtechMedical DevicesSt. Louis, US
Jonathan Silva(Executive Officer, Director)Berk Tas(Executive Officer, Director)inJames Patrick Howard(Executive Officer)
BoardSean Churchill(Director)Warren Watson(Director)
Co-investorsMissouri Technology CorporationService Provider CapitalCultivation Capital
Solis Agrosciences is an agricultural science company with a team focused on molecular sciences, plant transformation, and plant research.
AgTechBiotechFoodTechSaint Louis, US
Susan Martino-Catt(President and COO)inCharles Bolten(Director)Mary Fernandes(Executive Officer)Tom Cohen(Executive Officer, Director)inBrian Salmo(Director)
BoardDavid Smoller(Co-Founder & Director)in
Co-investorsMissouri Technology CorporationCultivation CapitalFINTOP Capital
Valo Health applies technology and data to drug discovery, working across the technology, biotech, and healthcare fields.
AI & Machine LearningBiotechHealthtech
David Berry(Founder)in
Co-investorsAtinum Investment Co. Ltd.Flagship PioneeringKoch Disruptive Technologies
Allotera (formerly Wugen) develops allogeneic T-cell therapies.
BiotechHealthtechMedical DevicesSt. Louis, US
Ayman Kabakibi(Executive Officer)inCherry Thomas(Executive Officer)inKumar Srinivasan(Executive Officer, Director)inKeith Vendola(Executive Officer)Daniel M Kemp(Executive Officer, Director)Matthew Cooper(Executive Officer)
Co-investorsAisling CapitalAlpha Wave GlobalRiverVest Venture PartnersAbingworthFidelity InvestmentsIntermediate Capital Group+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Accuronix TherapeuticsArch Oncology IncConfluenceGalera
Portfolio news
latest coverage across their companies
Valo · startbase.com · Aug 18, 2026
Solis Agrosciences · startupintros.com · Jul 13, 2026
Wugen · bizjournals.com · Jul 10, 2026
CoverCress · stlpartnership.com · Feb 13, 2026
Frequently asked questions
- How many investments has BioGenerator Ventures made?
- BioGenerator Ventures has 26 tracked investments, including 1 dated in the last 24 months.
- What stage does BioGenerator Ventures invest at?
- BioGenerator Ventures invests at the Pre-Seed, Seed, Series A, Series B stages.
- What is BioGenerator Ventures's typical check size?
- BioGenerator Ventures typically writes checks of $50K – $250K.
- What sectors does BioGenerator Ventures focus on?
- BioGenerator Ventures focuses on AgTech, Biotech, Digital Health, FoodTech, Healthtech, Medical Devices.
- Where is BioGenerator Ventures located?
- BioGenerator Ventures is headquartered in St. Louis, US.
- Does BioGenerator Ventures lead rounds?
- Yes, BioGenerator Ventures leads investment rounds.
- Who does BioGenerator Ventures co-invest with?
- BioGenerator Ventures most often shares deals with Missouri Technology Corporation, iSelect Fund, Fulcrum Global Capital, among 28 tracked co-investors.
Images
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Voima Ventures is a deep tech venture capital firm that backs founders building global solutions across people, planet, and industry, from technology spin-offs to scaling companies.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
VTC Ventures is an early-stage venture fund managed by Middleland Capital and backed by strategic LPs including Virginia Tech, the Fralin Biomedical Research Institute, and Carilion Clinic. It invests in healthcare, deep tech/defense/AI, and food & agriculture, offering founders access to clinical, research, and commercialization resources.
Lerer Hippeau is an early-stage venture capital firm that backs founders across sectors, emphasizing investing in companies before they gain wider recognition.